AR882 is an investigational selective uric acid transporter 1 inhibitor. The Food and Drug Administration (FDA) has granted Fast Track designation to AR882 for the treatment of clinically visible ...

Scientists at Georgia State University have used CRISPR gene editing to restore an ancient enzyme humans lost millions of years ago potentially reversing the buildup of uric acid that causes gout.

SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has designated its ...

During the Neogene period, humanity’s primate ancestors held a genomic advantage for combating gout. A new study found that the gene effectively lowered levels of uric acid and prevented ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Ilaris for the treatment of gout flares in adults, marking it as the first biologic therapy ...

More than 41 million people globally have gout. There is currently no cure for gout. Researchers from the Complutense University of Madrid have found a specific probiotic that helps lower the number ...

Here’s what you’ll learn when you read this story: During the Neogene period, humanity’s primate ancestors held a genomic advantage for combating gout. A new study found that the gene effectively ...